Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Extra high-dose arm and hand training early after stroke to improve upper-limb recovery

Official title: Efficacy of High-dosage, High-intensity Rehabilitation Program on the Motor Recovery After Stroke in Subacute Patients

Run by Adi Negev-Nahalat Eran · NCT07056049 · Data updated 2026-11-12

We will try extra technology-based arm and hand training in people 1–6 weeks after stroke to help them regain upper-limb movement.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorAdi Negev-Nahalat Eran
Academic / other
Locations2 sites (Ofakim and 1 other locations)
StatusRecruiting
StartedJuly 13, 2025
Main results expectedJanuary 15, 2027
Study endsJuly 15, 2027
Registry record updatedJuly 17, 2025
Trial IDNCT07056049 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18) 1–6 weeks after a confirmed ischemic or hemorrhagic stroke with at least 20° of active shoulder flexion, some wrist or finger movement, ability to give informed consent, and without severe spasticity, painful shoulder, unstable medical conditions, or major communication/cognitive deficits.

Probably not a fit

Patients with severe spasticity or non-neural loss of range of motion, a painful shoulder that limits reaching, major cognitive or communication impairments, or unstable medical conditions are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program enrolls adults 1–6 weeks after an ischemic or hemorrhagic stroke who retain some active shoulder and wrist/finger movement. Participants receive additional technology-based upper-extremity training for 120 minutes per day, five days a week, for four weeks on top of usual care. Outcomes are measured at baseline and followed for a total study duration of six months to track motor recovery. The protocol targets high-dosage, high-intensity repetitive practice during the subacute period when neuroplasticity may be greatest.

Why it matters

Potential benefit: If successful, patients could regain more arm and hand function and achieve greater independence in daily activities.

How similar studies have gone: Animal studies and some human trials suggest intensive early training can improve motor recovery, but clinical evidence is not yet conclusive and results have been mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Ischemic or hemorrhagic stroke (hemispheric or brainstem) confirmed by CT or MRI
* First-ever stroke or previous stroke with no upper extremity weakness
* 1 week ≤ Time after stroke onset ≤ 6 weeks
* Active shoulder flexion of at least 20◦ and partial wrist and/or finger active movement
* Ability to provide inform consent

Exclusion Criteria:

* A painful shoulder limiting an active forward reach
* Severe spasticity or non-neural loss of range of motion
* Cognitive or communication impairments as determined by the clinical team Unstable medical conditions

Where it's running

  • Adi Negev-Nahalat Eran
    Ofakim, Israel
    Recruiting
  • Adi Negev-Nahalat Eran
    Ofakim, Israel
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Psilocybin to reopen brain plasticity after chronic stroke

    This trial will test whether a supervised dose of psilocybin is safe and can help reopen brain plasticity in adults who had an ischemic or hemorrhagic stroke at least 12 months ago.

    Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT07053917

  • Deep phenotyping to explore recovery in young adults after stroke

    This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

    Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

  • Stem cell therapy for chronic stroke recovery

    This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

    Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

  • AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

    This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

  • Web-based therapy using action observation and mirror therapy for arm weakness after stroke

    This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.

    Recruiting Chang Gung Memorial Hospital · Taoyuan · NCT07921108

  • Remote Ischaemic Conditioning for Fatigue After Stroke 2

    Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.

    Recruiting Phase 2 Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, South Yorkshire · NCT07914647

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.